Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S, COMPASS Investigators

Open source

DOI: 10.1016/s0140-6736(17)32409-1
Published: 2018 Jan 20
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-17-32409-1,
  title = {Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.},
  author = {Anand SS and Bosch J and Eikelboom JW and Connolly SJ and Diaz R and Widimsky P and Aboyans V and Alings M and Kakkar AK and Keltai K and Maggioni AP and Lewis BS and Störk S and Zhu J and Lopez-Jaramillo P and O'Donnell M and Commerford PJ and Vinereanu D and Pogosova N and Ryden L and Fox KAA and Bhatt DL and Misselwitz F and Varigos JD and Vanassche T and Avezum AA and Chen E and Branch K and Leong DP and Bangdiwala SI and Hart RG and Yusuf S and COMPASS Investigators},
  year = {2018},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(17)32409-1},
  url = {https://doi.org/10.1016/s0140-6736(17)32409-1}
}

RIS

TY  - JOUR
TI  - Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
AU  - Anand SS
AU  - Bosch J
AU  - Eikelboom JW
AU  - Connolly SJ
AU  - Diaz R
AU  - Widimsky P
AU  - Aboyans V
AU  - Alings M
AU  - Kakkar AK
AU  - Keltai K
AU  - Maggioni AP
AU  - Lewis BS
AU  - Störk S
AU  - Zhu J
AU  - Lopez-Jaramillo P
AU  - O'Donnell M
AU  - Commerford PJ
AU  - Vinereanu D
AU  - Pogosova N
AU  - Ryden L
AU  - Fox KAA
AU  - Bhatt DL
AU  - Misselwitz F
AU  - Varigos JD
AU  - Vanassche T
AU  - Avezum AA
AU  - Chen E
AU  - Branch K
AU  - Leong DP
AU  - Bangdiwala SI
AU  - Hart RG
AU  - Yusuf S
AU  - COMPASS Investigators
PY  - 2018
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(17)32409-1
UR  - https://doi.org/10.1016/s0140-6736(17)32409-1
ER  -

APA

SS, A., J, B., JW, E., SJ, C., R, D., P, W., V, A., M, A., AK, K., K, K., AP, M., BS, L., S, S., J, Z., P, L., M, O., PJ, C., D, V., N, P., L, R., KAA, F., DL, B., F, M., JD, V., T, V., AA, A., E, C., K, B., DP, L., SI, B., RG, H., S, Y., & Investigators, C. (2018). Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(17)32409-1

Source records

pubmed · retrieved 2026-09-26T03:25:23.917Z